Porcine-Derived Chondroitin Sulfate Sodium Alleviates Osteoarthritis in HTB-94 Cells and MIA-Induced SD Rat Models
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020521 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Hyelim Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Clinical Nutrition, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Chondroitin Sulfates, Osteoarthritis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Osteoarthritis (OA) is a chronic disease characterized by cartilage degradation, leading to bone friction, inflammation, stiffness, pain, and reduced mobility. This study investigates the therapeutic effects of porcine-derived chondroitin sulfate sodium (CS) on OA symptoms at both cellular and animal levels. In vitro study, HTB-94 chondrocytes were treated with inflammatory stimuli and CS (10, 50, 100, and 200 μg/mL) to assess the release of inflammatory mediators and the expression of genes and proteins related to cartilage synthesis and degradation. In vivo study, an MIA-induced OA rat model was used, and CS (62, 124, and 248 mg/kg b.w.) was orally administered for 4 weeks. Key parameters, such as exercise capacity, micro-CT, histological evaluation of joint tissues, serum inflammatory markers, and the expression of mRNA and proteins (inflammatory, cartilage synthesis and degradation, and apoptosis markers), were analyzed. Porcine-derived CS significantly reduced PGE2, NO, and extracellular matrix degradation marker (COMP and CTX-II) levels and increased the expression of cartilage synthesis-related genes and proteins in both HTB-94 cells and the MIA-induced rats. Additionally, CS modulated cartilage degradation pathways and notably inhibited apoptosis in vivo. The effects of porcine CS were comparable to the NSAID ibuprofen, demonstrating its potential as an anti-inflammatory and chondroprotective agent for OA management and dietary supplementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute of Clinical Nutrition, Kyung Hee University, Seoul 02447, Republic of Korea.
- R&D Division, Daehan Chemtech Co., Ltd., Seoul 01811, Republic of Korea.
- Department of Food Innovation and Health, Kyung Hee University, Yongin 17104, Republic of Korea.
- Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22903, USA.
ORCID-Profile: Seong-Hoo Park, Jinhak Kim, Yuri Gwon, Minhee Lee, Soo-Jeung Park
Zitieren
APA
Kim, H., Kim, J., Park, S. H., Kim, J., Gwon, Y., Lee, M., & Park, S. J. (2025). Porcine-Derived Chondroitin Sulfate Sodium Alleviates Osteoarthritis in HTB-94 Cells and MIA-Induced SD Rat Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020521
Vancouver
Kim H, Kim J, Park SH, Kim J, Gwon Y, Lee M, et al. Porcine-Derived Chondroitin Sulfate Sodium Alleviates Osteoarthritis in HTB-94 Cells and MIA-Induced SD Rat Models. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020521
BibTeX
@article{Kim2025,
author = {Kim, Hyelim and Kim, Jinhee and Park, Seong-Hoo and Kim, Jinhak and Gwon, Yuri and Lee, Minhee and Park, Soo-Jeung},
title = {Porcine-Derived Chondroitin Sulfate Sodium Alleviates Osteoarthritis in HTB-94 Cells and MIA-Induced SD Rat Models},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020521}
}
EUVIMED